Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tardive dyskinesia model in the common marmoset.

Rebecka Klintenberg1, Lars Gunne, Per E Andrén

  • 1Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.

Movement Disorders : Official Journal of the Movement Disorder Society
|March 29, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spatial lipidomic and neuron-specific transcriptomic signatures in the nucleus accumbens reveal phospholipid dyshomeostasis in depression-related maladaptations.

Translational psychiatry·2026
Same author

Semaglutide Prevents Aortic Rupture and Dissection in the Angiotensin II Mouse Model.

Biomedicines·2026
Same author

Spatial lipidomics identifies α-synuclein-induced lipid changes in an AAV-induced Parkinsonian mouse model.

Neurobiology of disease·2026
Same author

Chromogranin A and catestatin regulate pancreatic islet homeostasis, endocrine function, and neurotransmitter signaling.

Communications biology·2025
Same author

Distribution of photosensitive fagopyrin in buckwheat flowers and its potential biological relevance.

Scientific reports·2025
Same author

The CHCHD2-CHCHD10 protein complex is modulated by mitochondrial dysfunction and alters lipid homeostasis in the mouse brain.

Cell death & disease·2025
Same journal

Putamen Structural-Functional Decoupling as an Early-Stage Candidate Imaging Marker for Motor Severity in Spinocerebellar Ataxia Type 3.

Movement disorders : official journal of the Movement Disorder Society·2026
Same journal

Melanopsin-Mediated Post-Illumination Pupillary Response in Idiopathic Rapid Eye Movement (REM) Sleep Behavior Disorder and Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2026
Same journal

High-Fat Diet Exacerbates Neuropathology in a Transgenic Mouse Model of Multiple System Atrophy.

Movement disorders : official journal of the Movement Disorder Society·2026
Same journal

Addressing the Challenges of Translating LRRK2 Biology into Disease-Modifying Therapies: The LRRK2 Investigative Therapeutics Exchange Initiative.

Movement disorders : official journal of the Movement Disorder Society·2026
Same journal

The LRRK2 G2385R Exonic Variant and Multiple System Atrophy: Findings from the Japan MSA Registry.

Movement disorders : official journal of the Movement Disorder Society·2026
Same journal

Alkaline Phosphatases: A Potential Cause of Variability in Therapeutic Response to Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion?

Movement disorders : official journal of the Movement Disorder Society·2026
See all related articles

Common marmosets developed tardive dyskinesia (TD) after long-term haloperidol treatment, showing persistent symptoms. This marmoset model may help screen antipsychotics for TD-inducing potential.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Primatology

Background:

  • Long-term antipsychotic use can lead to tardive dyskinesia (TD), a serious neurological disorder.
  • Animal models are crucial for understanding TD mechanisms and developing safer treatments.

Purpose of the Study:

  • To investigate the development of TD in common marmosets (Callithrix jacchus) following chronic haloperidol decanoate administration.
  • To evaluate the potential of the marmoset model for screening antipsychotic drugs regarding their TD-inducing liability.

Main Methods:

  • Thirteen adult marmosets received monthly injections of haloperidol decanoate for one year.
  • Animals were monitored for TD symptoms, and the effects of drug withdrawal and administration of anticholinergic drugs (biperiden) and nondepot haloperidol were assessed.

Related Experiment Videos

  • Acute dystonia was induced by weekly injections of nondepot haloperidol at the end of the study.

    • Main Results:

    • Twelve out of thirteen marmosets developed TD symptoms, including facial and limb movements, persisting for at least 5 months after treatment cessation.
    • Biperiden exacerbated TD symptoms, while nondepot haloperidol temporarily reduced them.
    • Acute dystonia, characterized by specific motor behaviors, was precipitated by nondepot haloperidol, with partial reduction by biperiden.

    Conclusions:

    • Chronic haloperidol decanoate administration reliably induces a TD syndrome in common marmosets.
    • This marmoset model offers a valuable tool for preclinical screening of antipsychotic medications to predict their risk of causing TD.